SCHEMBL2015884

SCHEMBL2015884

Cc1noc(C)c1C(=O)N1CCN(c2c(CCNc3ncnc4[nH]cnc34)cc(Cl)c3cccnc23)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TSHR P16473 2/20 0.40
POLB P06746 1/20 0.38
ALDH1A1 P00352 6/20 0.37
HSD17B10 Q99714 6/20 0.37
CYP3A4 P08684 2/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 3/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
CYP2D6 P10635 1/20 0.35
EPHX2 P34913 2/20 0.35
HTT P42858 2/20 0.35
NPC1 O15118 1/20 0.35
MPI P34949 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2015850 0.85 L3MBTL1 (0.37) KDM4ESMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL2012342 0.85 MAPT (0.42) KDM4ESMN1; SMN2MEN1KMT2ATSHR
SCHEMBL2163929 0.85 KDM4E (0.43) KDM4ESMN1; SMN2MEN1KMT2ATSHR
SCHEMBL2012273 0.84 HTT (0.39) KDM4ESMN1; SMN2MEN1KMT2ATSHR
SCHEMBL2014635 0.84 LMNA (0.40) KDM4ESMN1; SMN2KMT2ATSHRALDH1A1
SCHEMBL2016487 0.83 GBA1 (0.35) KDM4ESMN1; SMN2MEN1KMT2ATSHR
SCHEMBL2017028 0.83 LMNA (0.43) KDM4ESMN1; SMN2KMT2AALDH1A1MAPT
SCHEMBL2013342 0.83 KDM4E (0.52) KDM4ESMN1; SMN2MEN1KMT2ATSHR
SCHEMBL2015620 0.83 SMO (0.40) KDM4ESMN1; SMN2MEN1KMT2ATSHR
SCHEMBL2013837 0.83 BTK (0.37) KDM4ESMN1; SMN2MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO claimed
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed